Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Jianpi detoxification granules is a Traditional Chinese Medicine (TCM) formulation developed by Shenzhen Traditional Chinese Medicine Hospital for the treatment of chronic hepatitis B virus (HBV) carriers. The formulation is designed based on the TCM therapeutic principles of tonifying the kidney (Bushen), strengthening the spleen (Jianpi), and clearing heat/detoxifying (Jiedu). It is primarily investigated for its potential to induce HBsAg seroclearance or reduction and lower HBV-DNA levels in patients in the immune-tolerant phase of chronic hepatitis B. The granules are typically compared against other TCM protocols or placebos in clinical trials to optimize treatment strategies for HBV carriers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Jianpi detoxification granules.